Michael R Gold

Michael R Gold

FHRS MD PhD

Medical University of South Carolina, Charleston, SC

  • OrcidID

Biography

Dr Gold is the Michael E. Assey Professor of Medicine at the Medical University of South Carolina.

He has authored more than 200 articles in peer-reviewed journals, in addition to over 30 book chapters. He has been the PI or served on the Steering Committee of more than 15 multi-national clinical trials. Dr. Gold sits on the editorial board of several peer-reviewed journals, including American Journal of Cardiology, PACE, and the Journal of Cardiac Electrophysiology, and is a Section Editor for Heart Rhythm.

His major clinical research interests are defibrillator optimization, risk stratification for sudden cardiac death and pacing for congestive heart failure, and he is the national or global PI of several clinical studies. He attended medical school at the University of Colorado after completing his PhD in Physiology at the University of Virginia. He completed his postdoctoral training at Massachusetts General Hospital in Boston.

Read more

Media

Richard Schilling, Jason G Andrade, Boris Schmidt, et al

AHA 21 SMART-CRT: Effects of AV Optimization on CRT Outcomes

Michael R Gold,

Watch time: 8m 26s

Anushka Patel, Stephen Nicholls, Jeffrey Weitz, et al

Watch time: 2h 34m 53s (15 videos)

Cecilia Linde, Wilfried Mullens, Michael R Gold, et al

Watch time: 1h 1m 28s
HRS 2020: UNTOUCHED Trial Primary Results

Michael R Gold,

Watch time: 8m 16s
The S-ICD Post-Market Approval Study - Michael Gold

Michael R Gold,

Watch time: 5m 3s

Articles by Michael R Gold

The Role of Subcutaneous ICDs in the Prevention of Sudden Cardiac Death

Leah A John, Ahmadreza Karimianpour, Michael R Gold, et al

Published:

Citation: US Cardiology Review 2021;15:e19.

DOI:

https://doi.org/10.15420/usc.2021.01
The Subcutaneous ICD: A Review of the UNTOUCHED and PRAETORIAN Trials

Ahmadreza Karimianpour, Leah John, Michael R Gold, et al

Published:

Citation: Arrhythmia & Electrophysiology Review 2021;10(2):108–12.

DOI:

https://doi.org/10.15420/aer.2020.47
The Subcutaneous Implantable Cardioverter-Defibrillator: New Insights and Expanding Populations

Thomas A Turnage, John A Kpaeyeh, Michael R Gold, et al

Citation: US Cardiology Review 2018;12(1):66–70.

DOI:

https://doi.org/10.15420/usc.2017:37:1
Developments in Cardiac Resynchronisation Therapy

Geoffrey F Lewis, Michael R Gold,

Citation: Arrhythmia & Electrophysiology Review 2015;4(2):122–8

DOI:

https://doi.org/10.15420/aer.2015.04.02.122
Update on Cardiac Resynchronisation Therapy for Heart Failure

David D Daly Jr, Michael R Gold,

Citation: European Cardiology Review 2014;9(2):100–3

DOI:

https://doi.org/10.15420/ecr.2014.9.2.100